The world cheers a Covid-19 vaccine, but Zoom and other beneficiaries of pandemic pay a price

Patent waiver seen stalling vaccine production in Nigeria

COVAX has secured enough vaccines to achieve 45 percent of coverage across countries by the middle of this year

Global firms which have been the major beneficiaries of the coronavirus pandemic and the disruption it caused to the normal order of life and business, have seen their fortunes plummet Monday after credible news that the world is on the verge of a vaccine to fight the scourge. Promising results f

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```